Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/3803
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dilbar Muradovna Almuradova , Dilsora Ilhomovna Mukumova ,Xadicha Khasanovna Turaeva ,Karlibaev Azamat Orazbaevich | - |
dc.date.accessioned | 2022-10-12T14:12:59Z | - |
dc.date.available | 2022-10-12T14:12:59Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/3803 | - |
dc.description.abstract | Breast cancer is the most common cancer affecting women, with a one in seven lifetime risk. Estrogen receptor-positive (ER-positive) breast cancer is the most common type of breast cancer diagnosed today.Each year, approximately two million women are diagnosed with breast cancer worldwide. Estrogen receptor (ER)-positive and/or progesterone receptor (PgR)-positive breast cancer accounts for approximately 70% of all breast cancers, and 85% of those in women over 70 years of age. | en_US |
dc.language.iso | other | en_US |
dc.publisher | Other | en_US |
dc.subject | Breast cancer, Estrogen receptor-positive, progesterone receptor (PgR)-positive breast cancer, endocrine therapy, locally advanced breast cancer (LABC) | en_US |
dc.title | Modern endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer | en_US |
dc.type | Article | en_US |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Образование и наука в XXI веке -2.pdf | Modern endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer | 1.18 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.